Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
16 Jun 2021
Two new studies reported on infections in fully vaccinated people, while another looked at the rate of myocardial infarction and stroke in patients with COVID-19. A survey found depression and anxiety to be common during the pandemic, and the push for mandatory vaccination of health care workers continued.
4 Aug 2021
Multiple studies found changed patterns in cardiac emergencies and care associated with the pandemic, and the NIH's COVID-19 guideline panel recommended baricitinib for patients on high-flow oxygen or noninvasive ventilation.
9 Jun 2021
Several journal articles described recently implemented strategies for isolation, education, testing, visitors, and staff support, while others called for research collaboration and support for female hospitalists.
29 Jul 2020
The NIH updated its guidelines; recent research looked at interleukin-6 (IL-6) inhibitors, ivermectin, remdesivir, and hydroxychloroquine in COVID-19; and one study estimated that 23.2% of inpatient COVID-19 deaths last spring and summer could relate to hospital strain.
14 Jul 2021
A negative chest X-ray ruled out severe outcomes in many ED patients, and long-term effects were common after hospitalization, studies found. Vaccine research highlighted health care workers' reluctance to get vaccinated and the safety and efficacy of the latest vaccine candidate.
3 Feb 2021
First COVID-19 vaccine receives interim recommendation, new data, guidance on baricitinib plus remdesivir, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. New research looked at combination therapy for hospitalized patients and risk factors for in-hospital death.
16 Dec 2020
Remdesivir appeared to be of benefit in one study but was associated with increased length of stay and no improvement in survival in another, an industry-funded trial found no benefit for canakinumab in severe COVID-19, and the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine.
21 Jul 2021
The percentage of urine tests that were positive for illicit drugs increased, an ED saw more nonfatal opioid overdoses, and experts offered hospitalist-specific advice on handling substance use disorders.
30 Sep 2020
A British study highlighted the disproportionate effect of COVID-19 on black pregnant women, and articles by physicians urged action against racism and racial disparities.
17 Jun 2020